Spinal activators TRPV1. The endogenous agonists of spinal TRPV1 remain unclear; however, a number of possible substances have been suggested, including anandamide, metabolites of lipoxygenases, ω-3 polyunsaturated fatty acids, N-arachidonoyldopamine (NADA), and N-oleoyldopamine (OLDA).